"Osteosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Descriptor ID |
D012516
|
| MeSH Number(s) |
C04.557.450.565.575.650 C04.557.450.795.620
|
| Concept/Terms |
Osteosarcoma- Osteosarcoma
- Osteosarcomas
- Osteosarcoma Tumor
- Osteosarcoma Tumors
- Tumor, Osteosarcoma
- Tumors, Osteosarcoma
- Sarcoma, Osteogenic
- Osteogenic Sarcomas
- Sarcomas, Osteogenic
- Osteogenic Sarcoma
|
Below are MeSH descriptors whose meaning is more general than "Osteosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Osteosarcoma".
This graph shows the total number of publications written about "Osteosarcoma" by people in this website by year, and whether "Osteosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 0 | 3 | 3 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 4 | 2 | 6 |
| 2009 | 5 | 0 | 5 |
| 2010 | 4 | 1 | 5 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 8 | 0 | 8 |
| 2015 | 9 | 2 | 11 |
| 2016 | 6 | 0 | 6 |
| 2017 | 5 | 1 | 6 |
| 2018 | 3 | 1 | 4 |
| 2019 | 6 | 1 | 7 |
| 2020 | 5 | 0 | 5 |
| 2021 | 6 | 1 | 7 |
| 2022 | 6 | 0 | 6 |
| 2023 | 5 | 0 | 5 |
| 2024 | 5 | 1 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteosarcoma" by people in Profiles.
-
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2024 Dec 01; 10(12):1645-1653.
-
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models. Clin Cancer Res. 2024 Oct 01; 30(19):4434-4449.
-
Intrinsic Epigenetic State of Primary Osteosarcoma Drives Metastasis. Mol Cancer Res. 2024 09 04; 22(9):864-878.
-
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models. Sci Rep. 2024 08 27; 14(1):19891.
-
Primary extraskeletal osteosarcomas of the pleura: A clinicopathological, immunohistochemical, and molecular analysis of 4 cases. Hum Pathol. 2024 10; 152:105635.
-
Mapping the Single-Cell Differentiation Landscape of Osteosarcoma. Clin Cancer Res. 2024 Aug 01; 30(15):3259-3272.
-
Machine learning and experimental analyses identified miRNA expression models associated with metastatic osteosarcoma. Biochim Biophys Acta Mol Basis Dis. 2024 10; 1870(7):167357.
-
Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Pediatr Blood Cancer. 2024 Oct; 71(10):e31189.
-
Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board. Anticancer Res. 2024 Jul; 44(7):2765-2768.
-
Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough? Ann Thorac Surg. 2025 Mar; 119(3):616-624.